Search research articles
Contact Us
Filters
Showing results (91-100 of 117) with videos related to
Page
of 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2015
Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells
Chitra Venugopal, Robin Hallett, Parvez Vora, et al.
Acta Neuropathologica
|
August 3, 2017
RNAi screen identifies essential regulators of human brain metastasis-initiating cells
Mohini Singh, Chitra Venugopal, Tomas Tokar, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 13, 2023
An HLA-G/SPAG9/STAT3 axis promotes brain metastases
Blessing Iquo Bassey-Archibong, Chirayu Rajendra Chokshi, Nikoo Aghaei, et al.
Cancer Research
|
June 28, 2018
Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma
Maleeha A Qazi, Parvez Vora, Chitra Venugopal, et al.
Cancer Research
|
September 11, 2013
Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children
Joanna Triscott, Cathy Lee, Colleen Foster, et al.
International Journal of Cancer
|
April 24, 2026
Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for Glioblastoma
Sabra K Salim, Muhammad Vaseem Shaikh, Jeffrey Wei, et al.
Journal of Medicinal Chemistry
|
February 19, 2019
Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer
Andrew E Shouksmith, Fenil Shah, Michelle L Grimard, et al.
Journal for Immunotherapy of Cancer
|
January 12, 2022
CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment
Mathieu Seyfrid, William Thomas Maich, Vaseem Muhammad Shaikh, et al.
Journal of Medicinal Chemistry
|
February 4, 2022
Discovery of HDAC6-Selective Inhibitor NN-390 with <i>in Vitro</i> Efficacy in Group 3 Medulloblastoma
Nabanita Nawar, Shazreh Bukhari, Ashley A Adile, et al.
Science Advances
|
December 8, 2021
Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence
David Bakhshinyan, Ashley A Adile, Jeff Liu, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 117) with videos related to
Sort By:
Page
of 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2015
Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells
Chitra Venugopal, Robin Hallett, Parvez Vora, et al.
Acta Neuropathologica
|
August 3, 2017
RNAi screen identifies essential regulators of human brain metastasis-initiating cells
Mohini Singh, Chitra Venugopal, Tomas Tokar, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 13, 2023
An HLA-G/SPAG9/STAT3 axis promotes brain metastases
Blessing Iquo Bassey-Archibong, Chirayu Rajendra Chokshi, Nikoo Aghaei, et al.
Cancer Research
|
June 28, 2018
Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma
Maleeha A Qazi, Parvez Vora, Chitra Venugopal, et al.
Cancer Research
|
September 11, 2013
Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children
Joanna Triscott, Cathy Lee, Colleen Foster, et al.
International Journal of Cancer
|
April 24, 2026
Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for Glioblastoma
Sabra K Salim, Muhammad Vaseem Shaikh, Jeffrey Wei, et al.
Journal of Medicinal Chemistry
|
February 19, 2019
Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer
Andrew E Shouksmith, Fenil Shah, Michelle L Grimard, et al.
Journal for Immunotherapy of Cancer
|
January 12, 2022
CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment
Mathieu Seyfrid, William Thomas Maich, Vaseem Muhammad Shaikh, et al.
Journal of Medicinal Chemistry
|
February 4, 2022
Discovery of HDAC6-Selective Inhibitor NN-390 with <i>in Vitro</i> Efficacy in Group 3 Medulloblastoma
Nabanita Nawar, Shazreh Bukhari, Ashley A Adile, et al.
Science Advances
|
December 8, 2021
Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence
David Bakhshinyan, Ashley A Adile, Jeff Liu, et al.
Page
of 12